Literature DB >> 2475063

Systemic Salmonella infections in sickle cell anaemia.

D K Webb1, G R Serjeant.   

Abstract

Salmonella infections remain a significant cause of morbidity and mortality in patients with sickle cell disease. In Jamaica, 16 episodes of systemic Salmonella infection were recognized in 308 children with sickle cell disease followed prospectively in a cohort study from birth. There were eight cases with osteomyelitis, seven with septicaemia, and one with meningitis. Salmonella dactylitis was the commonest presentation of osteomyelitis in the young child. Comparison of clinical features between children with Salmonella dactylitis and dactylitis owing to avascular bone necrosis showed that children with osteomyelitis had significantly higher fever, prolonged history and fluctuant swellings. Fever above 38.5 degrees C occurred in four of five children with Salmonella dactylitis, but in only one of 59 with uncomplicated dactylitis (P = 0.01). Chloramphenicol and co-trimoxazole were both effective for systemic infection, and ampicillin alone was inadequate. Three deaths occurred, two from septicaemia and one from meningitis.

Entities:  

Mesh:

Year:  1989        PMID: 2475063     DOI: 10.1080/02724936.1989.11748623

Source DB:  PubMed          Journal:  Ann Trop Paediatr        ISSN: 0272-4936


  3 in total

1.  Synthesis, characterization, and immunological properties in mice of conjugates composed of detoxified lipopolysaccharide of Salmonella paratyphi A bound to tetanus toxoid with emphasis on the role of O acetyls.

Authors:  E Konadu; J Shiloach; D A Bryla; J B Robbins; S C Szu
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

2.  Protection of mice against Salmonella typhimurium with an O-specific polysaccharide-protein conjugate vaccine.

Authors:  D C Watson; J B Robbins; S C Szu
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

3.  Nontyphoidal, nonparatyphoidal salmonella septicemia in adults.

Authors:  F J Roberts
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-03       Impact factor: 3.267

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.